Pharmaceutical giant AbbVie and Northwestern University have inked a five-year deal to collaborate on cancer research.
As part of the agreement, scientists at Northwestern’s Lurie Cancer Center in Streeterville will be able to access new therapies developed by North Chicago-based AbbVie for research funded under the deal. AbbVie will be able to exclusively license any discoveries made during their collaboration.
“One of the best steps AbbVie can take to deliver new therapies in oncology is to combine our research and discovery expertise with the talents and insight of our colleagues in academic medicine,” Dr. Gary Gordon, AbbVie’s vice president of oncology clinical development, said in a joint statement announcing the deal…
[“source-smallbiztrends”]
